Max Waschbusch

Max Waschbusch is an accomplished leader in the pharmaceutical industry with extensive experience in medical affairs and clinical safety. Currently serving as Head of Plasma Donor Safety at CSL since April 2020, Waschbusch has held various leadership roles, including TA Head for Cardiovascular and Metabolism therapeutic areas. Prior to this, a tenure at Sanofi as TA Head for Cardiovascular GPE involved providing pharmacovigilance expertise and oversight for therapeutic area teams. Waschbusch's background includes significant roles at Bristol-Myers Squibb, where responsibilities spanned from leading worldwide medical activities for established brands to managing the mature product portfolio across multiple countries. Early career experiences include positions as Medical Director at Spedrog Caillon and Medical Advisor for CNS at Organon. Educational qualifications include an MD in Medicine from the University of Buenos Aires and specialties in Internal Medicine and Critical Care from respected Argentine institutions.